Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Capocard tablets (25 mg captopril) Produced by Dar AlDawa / Jordan versus Capoten® tablets (25 mg captopril) Produced by SPIMACO / KSA, in healthy subjects under fasting condition.

drug protocol number
Jul-17
drug sponsor
SFDA
drug study
Capocard
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase